The expanding role of co-trimoxazole in developing countries.

The expanding role of co-trimoxazole in developing countries.

Show other versions (1)

Co-trimoxazole is an inexpensive, broad-spectrum antimicrobial drug that is widely used in developing countries. Before antiretroviral therapy (ART) scale-up, co-trimoxazole prophylaxis reduced morbidity and mortality in adults and children with HIV by preventing bacterial infections, diarrhoea, mal...

Full description

Bibliographic Details
Main Authors:	Church, J, Fitzgerald, F, Walker, A, Gibb, D, Prendergast, A
Format:	Journal article
Language:	English
Published:	2014

Similar Items

The expanding role of co-trimoxazole in developing countries.
by: Church, J, et al.
Published: (2015)

Co-trimoxazole for HIV-exposed uninfected infants
by: Ceri Evans, et al.
Published: (2017-05-01)

Co-trimoxazole prophylaxis in African children with HIV-1 - Reply
by: Gibb, D, et al.
Published: (2005)

CO-TRIMOXAZOLE AND BLOOD
by: Fleming, A, et al.
Published: (1974)

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
by: Bwakura-Dangarembizi, M, et al.
Published: (2014)

Letter: Co-trimoxazole and the blood.
by: Fleming, A, et al.
Published: (1974)

Co‐trimoxazole prophylaxis for children who are HIV‐exposed and uninfected: a systematic review
by: Catherine J. Wedderburn, et al.
Published: (2023-06-01)

Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy
by: Eleanor Hutchinson, et al.

Role of co-trimoxazole in current medical practice
by: Ekadashi Rajni, et al.
Published: (2024-05-01)

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
by: Crook, A, et al.
Published: (2016)

Will co-trimoxazole resistance rates ever go down? Resistance rates remain high despite decades of reduced co-trimoxazole consumption
by: Pouwels, K, et al.
Published: (2017)

Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis
by: MRH Roushan, et al.
Published: (2004-09-01)

Acute polyneuropathy possibily associated with co-trimoxazole.
by: Grossman, AB, et al.
Published: (1977)

Epidermic toxic necrolysis induced by co-trimoxazole
by: Rolando Rodríguez Hernández, et al.
Published: (2016-11-01)

Efficacy of Co-trimoxazol and Rifampine in treatment of childhood Brucellosis
by: MR Hassanjani Roshan, et al.
Published: (2000-10-01)

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
by: Walker, A, et al.
Published: (2010)

Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
by: Chintu, C, et al.
Published: (2004)

Malaria, sickle cell disease, HIV, and co-trimoxazole prophylaxis: An observational study
by: Ewurama D.A. Owusu, et al.
Published: (2018-04-01)

Incidence of Co-Trimoxazole-Induced Hyperkalemia in a Tertiary Care Hospital
by: Al AdAwi RM, et al.
Published: (2021-02-01)

Resistance gene pool to co-trimoxazole in non-susceptible Nocardia strains.
by: Sylvia eValdezate, et al.
Published: (2015-04-01)

Correction to: The role of oral co-trimoxazole in treating Nocardia farcinica keratitis: a case report
by: Neharika Sharma, et al.
Published: (2018-01-01)

A comparative study on efficacy of Co-trimoxazole and Permethrin for treatment of pediculosis capitis
by: A.Borghei (MD), et al.
Published: (2006-07-01)

Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.
by: Hasse, B, et al.
Published: (2014)

Efficacy and safety of co-trimoxazole in eradication phase of melioidosis; systematic review
by: Keragala Arachchige Reshani Kaumada Keragala, et al.
Published: (2023-08-01)

Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV
by: Anand A Date, et al.
Published: (2010-04-01)

Comparison of Efficacy of Ciprofloxacin and Co-Trimoxazole in Escherichia Coli Urinary Tract Infection
by: Muhammad Ayaz, et al.
Published: (2024-05-01)

Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997
by: Jihad Bishara, et al.
Published: (2003-09-01)

A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis.
by: Rajchanuvong, A, et al.
Published: (1995)

Co‐Trimoxazole‐Induced Toxic Epidermal Necrolysis: A Case Report From Nepal
by: Sandesh Gaire, et al.
Published: (2024-12-01)

A rare case of Co-trimoxazole induced hyperkalemia in a child with acute leukaemia
by: Richa, et al.
Published: (2024-01-01)

Azithromycin Versus Co-trimoxazole in The Treatment of Doxycycline Resistant Acne Vulgaris In Iraqi Patients
by: Basman M. Fadheel
Published: (2013-04-01)

Comparison of Co-trimoxazole and Cephalexin Efficacy in Preventing Urinary Tract Infection among Children
by: Jabar Parhiz, et al.
Published: (2021-04-01)

Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement
by: Zycinska K, et al.
Published: (2009-12-01)

Minimal inhibitory concentration of ceftazidime and Co-trimoxazole for Stenotrophomonas maltophilia using E-test
by: Firoozeh Jamali, et al.
Published: (2011-01-01)

Quality assessment of selected co-trimoxazole suspension brands marketed in Nairobi County, Kenya.
by: Beatrice Njeri Irungu, et al.
Published: (2021-01-01)

Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review.
by: Christine Manyando, et al.
Published: (2013-01-01)

Can HIV treatments inform other contexts? A trial of an additional indication for co-trimoxazole prophylaxis.
by: Ngari, M, et al.
Published: (2017)

Detection of antibodies to co-trimoxazole (preservative drug) interfering with routine red cell antibody screening
by: Deepti Sachan, et al.
Published: (2018-01-01)

The Effect of Oral Co-trimoxazole on Decreasing Bacterial Adherence and Biofilm Formation on Ureteral Stents Surfaces
by: Mohammed S. Abdel-Kader, et al.
Published: (2020-01-01)

The benefit of co-trimoxazole treatment in the management of acute watery diarrhea caused by invasive bacterial infection
by: Bobby Setiadi Dharmawan, et al.
Published: (2007-07-01)